$1.90
0.010.53%
At close: -
$1.91
0.010.53%
After Hours: 6:14 PM EDT
Comments
Loading...
Akebia Therapeutics (AKBA) Forecast
NewsEarningsAkebia Therapeutics (AKBA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Akebia Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:AKBA | Benzinga
Explore Akebia Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AKBA.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Akebia Therapeutics (AKBA) stock?
You can purchase shares of Akebia Therapeutics (NASDAQ:AKBA) through any online brokerage.
Who are Akebia Therapeutics (AKBA) competitors?
Other companies in Akebia Therapeutics’s space includes: Valneva (NASDAQ:VALN), Precigen (NASDAQ:PGEN), Cogent Biosciences (NASDAQ:COGT), Upstream Bio (NASDAQ:UPB) and Replimune Group (NASDAQ:REPL).
What is the forecast, or price target, for Akebia Therapeutics (AKBA) stock?
Akebia Therapeutics has a consensus price target of $5.50.
What is the current price for Akebia Therapeutics (AKBA)?
The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $1.91 last updated April 16, 2025 at 6:14 PM EDT.
Does Akebia Therapeutics (AKBA) pay a dividend?
There are no upcoming dividends for Akebia Therapeutics.
When is Akebia Therapeutics (NASDAQ:AKBA) reporting earnings?
Akebia Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Akebia Therapeutics (AKBA) going to split?
There is no upcoming split for Akebia Therapeutics.
What sector and industry does Akebia Therapeutics (AKBA) operate in?
Akebia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.